• database DOAJ indexed

United States · Current Science Inc.

lock Subscription · DOAJ

Current Hepatitis Reports

Current Hepatitis Reports is a journal indexed in SJR in Virology and Hepatology with an H index of . It has a price of 2500 €.

ISSN: 1540-3416

Publisher: Current Science Inc.

Category: Virology

Indexation: verifiedDOAJ

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

NPD

H-index NPD

Acceptance rate pie_chart

NPD

Source NPD

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.500 € Subscription

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

DOAJ

SJR Impact

—

H-index

—

Docs (year)

—

Docs 3y

—

Total refs

—

Cites 3y

—

Citable 3y

—

Cites/Doc 2y

—

Ref/Doc

—

Immediate OA

2500 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Current Management of HBV Antiviral Drug Resistance

Web alert

Goals of Antiviral Therapy for Hepatitis B: HBeAg Seroconversion, HBsAg Seroconversion, Histologic Improvement, and Possible Impact on Risk of Hepatocellular Carcinoma

Extrahepatic Manifestations of Hepatitis C Virus Infection: Mixed Cryoglobulinemia and Beyond

Ethnic and Racial Differences in the Natural History of Hepatitis C

Erratum to: The Role of Interferon Therapy in Patients With Hepatocellular Carcinoma

Erratum to: Cholestatic Hepatitis C in Immunocompromised Settings

Epigenetic Regulation of Hepatitis B Virus Infection

Drugs in Development for the Treatment of Chronic Hepatitis B

Depression and fatigue: Challenging comorbidities in HCV-infected patients

Current treatment of chronic HBV infection: An Asian-Pacific perspective

Current treatment of chronic HBV infection: A North American perspective

SHOW MORE ARTICLES

Current Management Strategies for Acute Esophageal Variceal Hemorrhage

A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B

Current Antiviral Therapy of Chronic Hepatitis B: Efficacy and Safety

Chronic hepatitis C in the Latino population

Chronic hepatitis C in minority populations

Cholestatic Hepatitis C in Immunocompromised Settings

Boceprevir versus Telaprevir: A New Era of Directly Acting Antiviral Therapy

Baseline and On-Treatment Predictors for Outcome of Chronic Hepatitis B Treatment

Autoantibodies in Hepatitis C Infection: What Do They Mean?

Antiviral therapy as an adjunct to passive-active immunotherapy for prevention of perinatal transmission of HBV

Alcohol abuse and chronic hepatitis C

Adherence to therapy: Challenges in HCV-infected patients

FAQs

SJR is not available (NPD) for Current Hepatitis Reports in the CountryOfPapers database.

Immediate OA APC is 2500 EUR. Non-OA / submission fee is 0 EUR.